Malaria News and Research

Latest Malaria News and Research

Profectus' GENEVAX IL-12 pDNA adjuvant improves vaccine-induced response rate in Phase I HIV study

Profectus Biosciences, Inc., a leader in the development of therapeutic and preventive vaccines against infectious diseases and cancers, announced today that its GENEVAX™ IL-12 pDNA adjuvant has significantly improved the vaccine-induced response rate in a Phase I clinical study of an experimental DNA vaccine for the prevention of HIV infection.

15 Dec 2010

Global Fund to draw up action plan against drug theft, invites stakeholders to participate

The Global Fund to Fight AIDS, Tuberculosis and Malaria on Friday appealed to international donors to join them in an effort to fight medicine theft, SAPA/News24 reports.

15 Dec 2010

Reuters looks at cost-effectiveness of pursuing malaria vaccine, eradication

Reuters examines the effort to create an effective malaria vaccine and asks: "[I]s the vaccine - and the global health community's aim of completely eradicating a disease that kills a child every 45 seconds - really worth the money?"

15 Dec 2010

Also in Global Health News: Drought in Middle East; HIV/AIDS, TB in Indonesia; MSF warnings over needs of HIV/AIDS patients; Non-profit at work in Uganda

Inter Press Service examines the effects a "devastating drought this fall" has had on farmers in the Middle East, particularly those living in Syria. Once "[a] large wheat exporter, the drought's impact has now forced the agriculturally self-reliant Syrian government to import the staple to meet local consumption," the news service writes.

15 Dec 2010

MVI, Merck and NYU collaborate to research potential malaria vaccine

Development of a vaccine to prevent the malaria parasite from entering the human liver is the goal of a new collaboration announced today by global leaders in malaria research and vaccine development. The PATH Malaria Vaccine Initiative (MVI), Merck (known outside the US and Canada as MSD), and NYU Langone Medical Center are working together to evaluate an approach targeting a novel part of a major surface protein on the malaria parasite. Malaria is estimated to kill close to 900,000 people each year with the majority of deaths occurring in children under the age of five in sub-Saharan Africa.

14 Dec 2010

New collaboration to develop vaccine to prevent malaria parasite from entering human liver

14 Dec 2010

Chimerix reports positive results from CMX157 Phase 1 clinical trial for HIV

Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today announced first-in-human Phase 1 clinical trial results for CMX157 demonstrating a favorable safety, tolerability and drug distribution profile.

14 Dec 2010

Opinions: Questioning WHO's relevance; Reforming foreign aid; Efforts to prevent child marriage

"The WHO - for 62 years the world's go-to agency on all public health matters - is today outmoded, underfunded, and overly politicized," Jack Chow, former assistant director-general on HIV/AIDS, tuberculosis and malaria at WHO, writes in a Foreign Policy Argument where he outlines some of the major issues facing the WHO, including personnel challenges, the agency's "archaic" governance system and a "new atmosphere, where [other] organizations are taking health into their own hands."

10 Dec 2010

Bacterium used to tackle Dengue fever

This January Australian scientists will start deploying a strange bacterium called Wolbachia pipientis in an attempt to halt disease transmission by mosquitoes especially Dengue fever. They are targeting the Aedes aegypti mosquito that transmits Dengue. Dengue is a viral disease that leads to high fever, severe muscle and joint pain and can also be fatal.

9 Dec 2010

Rapid TB test endorsed by WHO

The World Health Organization (WHO) said that a new test that can detect tuberculosis (TB), including drug-resistant forms, in less than two hours could revolutionize treatment of the disease. Tuberculosis is still a major killer worldwide killing 4,700 people every day last year. The annual death toll of 1.7 million includes 380,000 people who are at particular risk because they have HIV, the virus that depresses the immune system and causes Aids.

8 Dec 2010

Vaccine World Summit to be held in New Delhi 1-3 March, 2011

From the 1st to the 3rd of March 2011, vaccine leaders from developing and developed world will meet at Vaccine World Summit in New Delhi. The event will be hosted by IMAPAC, in partnership with DCVMN (Developing Countries Vaccine Manufacturers Network).

8 Dec 2010

European Commission must stop attacking generic medicines, says ITPC

On International Human Rights Day, as the European Commission (EC) and the Government of India meet in Brussels to finalise a European Union (EU)-India free trade agreement, the International Treatment Preparedness Coalition (ITPC) calls on Indian negotiators to put the right to health of its citizens and of the fifteen million HIV-positive people worldwide needing treatment above the pharmaceutical companies' interests and profits.

8 Dec 2010

Encouraging GenVec RSV vaccine program data presented at International Respiratory Syncytial Virus Symposium

GenVec, Inc. announced today that data were presented on GenVec's respiratory syncytial virus (RSV) vaccine program at the International Respiratory Syncytial Virus Symposium, which took place in Rotterdam, Netherlands on December 2-5, 2010. The presentation was given by Barney S. Graham, MD, PhD, Chief, Viral Pathogenesis Laboratory and Chief, Clinical Trials Core, at the Vaccine Research Center (VRC) of the National Institutes of Health (NIH).

7 Dec 2010

Health experts, mobile service providers discuss potential for mobile health in Africa at summit

"Some 80 health professionals and telecom operators [met last week for the mHealth Africa Summit] in the Ghanaian capital Accra to explore ways to use mobile phones for better healthcare delivery," IRIN reports in an article that details a variety of successful projects relaying health information through cell phones in Africa. The article describes how mobile phones are being used in Africa to educate populations about HIV/AIDS, tuberculosis and improve maternal health, as well as to track medicines and other health supplies, including mosquito nets.

7 Dec 2010

Ancora receives two federal grants to develop vaccine for malaria, staphylococcus aureus

Ancora Pharmaceuticals announced today that it received two federal grants under the Qualifying Therapeutic Discovery Program to continue funding its groundbreaking research and development of vaccine candidates to prevent malaria and infection by staphylococcus aureus.

7 Dec 2010

HP, mPedigree Network introduce life-saving service to fight counterfeit drugs in Africa

HP and African social enterprise mPedigree Network have introduced a potentially life-saving service that targets counterfeit pharmaceuticals by enabling people in Nigeria and Ghana to easily check the authenticity of their malaria medication.

6 Dec 2010

Research highlighting treatment for pediatric SCD, malaria presented at ASH 2010

Red blood cells have the very important role of carrying oxygen from the lungs to the rest of the body; therefore, disorders that affect RBCs can have a significant impact on quality of life. Sickle cell disease and malaria are two common RBC diseases that affect a significant portion of the U.S. and global populations. Sickle cell disease, a genetic blood disorder that causes deformed and dysfunctional red blood cells, affects an estimated 70,000 to 100,000 Americans, while malaria affects approximately 1,500 Americans annually and 190 to 311 million people worldwide.

6 Dec 2010

UIC scientist focuses on potential targets to inhibit malaria transmission

University of Illinois at Chicago researcher Dr. John Quigley will describe a promising new approach to blocking malaria transmission during the American Society of Hematology's annual meeting in Orlando, Fla.

6 Dec 2010

IDRI awarded $1.8M contract to develop adjuvant formulations for pandemic influenza

The Infectious Disease Research Institute has been awarded an $1.8 million contract from the Biomedical Advance Research and Development Authority. IDRI's work will focus on development of adjuvant formulations with options up to $8.5 million over three years when further development and manufacture of priority candidates are approved by the agency.

4 Dec 2010

IDRI receives $790,200 BARDA grant to develop pandemic flu vaccine

The Infectious Disease Research Institute (IDRI) today announced it has received a $790,200 grant from the Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and Human Services. The grant enables technology transfer between IDRI and the Cantacuzino National Institute of Research and Development for Microbiology and Immunology (Bucharest, Romania), with the goal of producing a pandemic flu vaccine.

4 Dec 2010

Malaria News and Research

Latest Malaria News and Research

Profectus' GENEVAX IL-12 pDNA adjuvant improves vaccine-induced response rate in Phase I HIV study

Global Fund to draw up action plan against drug theft, invites stakeholders to participate

Reuters looks at cost-effectiveness of pursuing malaria vaccine, eradication

Also in Global Health News: Drought in Middle East; HIV/AIDS, TB in Indonesia; MSF warnings over needs of HIV/AIDS patients; Non-profit at work in Uganda

MVI, Merck and NYU collaborate to research potential malaria vaccine

New collaboration to develop vaccine to prevent malaria parasite from entering human liver

Chimerix reports positive results from CMX157 Phase 1 clinical trial for HIV

Opinions: Questioning WHO's relevance; Reforming foreign aid; Efforts to prevent child marriage

Bacterium used to tackle Dengue fever

Rapid TB test endorsed by WHO

Vaccine World Summit to be held in New Delhi 1-3 March, 2011

European Commission must stop attacking generic medicines, says ITPC

Encouraging GenVec RSV vaccine program data presented at International Respiratory Syncytial Virus Symposium

Health experts, mobile service providers discuss potential for mobile health in Africa at summit

Ancora receives two federal grants to develop vaccine for malaria, staphylococcus aureus

HP, mPedigree Network introduce life-saving service to fight counterfeit drugs in Africa

Research highlighting treatment for pediatric SCD, malaria presented at ASH 2010

UIC scientist focuses on potential targets to inhibit malaria transmission

IDRI awarded $1.8M contract to develop adjuvant formulations for pandemic influenza

IDRI receives $790,200 BARDA grant to develop pandemic flu vaccine

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Malaria News and Research

Latest Malaria News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in